GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

olatorepatide   Click here for help

GtoPdb Ligand ID: 14425

Synonyms: HS-20094 | HS20094
Compound class: Peptide
Comment: Olatorepatide (HS-20094) is a dual gastric inhibitory polypeptide (GIP) receptor and glucagon like peptide 1 (GLP-1) receptor agonist [1].
No information available.
Summary of Clinical Use Click here for help
Olatorepatide (HS-20094) was progressed to clinical evaluations as a once-weekly injectable agent for the treatment of overweight/obesity and/or type 2 diabetes.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT07431086 Study of Olatorepatide in Adult Participants Living With Overweight or Obesity in the US Phase 2 Interventional Regeneron Pharmaceuticals
NCT06839664 A Study of HS-20094 in Chinese Adults with Overweight or Obesity Phase 3 Interventional Jiangsu Hansoh Pharmaceutical Co., Ltd.
NCT07156500 A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone Phase 3 Interventional Jiangsu Hansoh Pharmaceutical Co., Ltd.
NCT07156539 A Phase 3 Study of HS-20094 in Patients With T2DM Phase 3 Interventional Jiangsu Hansoh Pharmaceutical Co., Ltd.